• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SIRPA 是一种用于分离人多能干细胞来源的心肌细胞的特异性细胞表面标志物。

SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells.

机构信息

McEwen Centre for Regenerative Medicine, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada.

出版信息

Nat Biotechnol. 2011 Oct 23;29(11):1011-8. doi: 10.1038/nbt.2005.

DOI:10.1038/nbt.2005
PMID:22020386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4949030/
Abstract

To identify cell-surface markers specific to human cardiomyocytes, we screened cardiovascular cell populations derived from human embryonic stem cells (hESCs) against a panel of 370 known CD antibodies. This screen identified the signal-regulatory protein alpha (SIRPA) as a marker expressed specifically on cardiomyocytes derived from hESCs and human induced pluripotent stem cells (hiPSCs), and PECAM, THY1, PDGFRB and ITGA1 as markers of the nonmyocyte population. Cell sorting with an antibody against SIRPA allowed for the enrichment of cardiac precursors and cardiomyocytes from hESC/hiPSC differentiation cultures, yielding populations of up to 98% cardiac troponin T-positive cells. When plated in culture, SIRPA-positive cells were contracting and could be maintained over extended periods of time. These findings provide a simple method for isolating populations of cardiomyocytes from human pluripotent stem cell cultures, and thereby establish a readily adaptable technology for generating large numbers of enriched cardiomyocytes for therapeutic applications.

摘要

为了鉴定人类心肌细胞特有的细胞表面标志物,我们用一组 370 种已知的 CD 抗体对来源于人类胚胎干细胞(hESC)的心血管细胞群体进行了筛选。该筛选鉴定出信号调节蛋白 α(SIRPA)是一种特异性表达于来源于 hESC 和人诱导多能干细胞(hiPSC)的心肌细胞上的标志物,而 PECAM、THY1、PDGFRB 和 ITGA1 则是心肌细胞以外的细胞群体的标志物。用针对 SIRPA 的抗体进行细胞分选,可从 hESC/hiPSC 分化培养物中富集心脏前体细胞和心肌细胞,得到高达 98%的心肌肌钙蛋白 T 阳性细胞群体。当在培养中铺板时,SIRPA 阳性细胞在收缩,并能在较长时间内维持。这些发现为从人类多能干细胞培养物中分离心肌细胞群体提供了一种简单的方法,并因此建立了一种易于适应的技术,可用于产生大量用于治疗应用的富集心肌细胞。

相似文献

1
SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells.SIRPA 是一种用于分离人多能干细胞来源的心肌细胞的特异性细胞表面标志物。
Nat Biotechnol. 2011 Oct 23;29(11):1011-8. doi: 10.1038/nbt.2005.
2
SIRPA, VCAM1 and CD34 identify discrete lineages during early human cardiovascular development.信号调节蛋白α、血管细胞黏附分子1和CD34在人类早期心血管发育过程中识别不同的细胞谱系。
Stem Cell Res. 2014 Jul;13(1):172-9. doi: 10.1016/j.scr.2014.04.016. Epub 2014 May 4.
3
Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression.通过 VCAM1 表面表达从人胚胎和诱导多能干细胞中高效且规模化纯化心肌细胞。
PLoS One. 2011;6(8):e23657. doi: 10.1371/journal.pone.0023657. Epub 2011 Aug 18.
4
NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes.NKX2-5(eGFP/w) 人胚胎干细胞用于分离人心肌祖细胞和心肌细胞。
Nat Methods. 2011 Oct 23;8(12):1037-40. doi: 10.1038/nmeth.1740.
5
Isolation of Cardiomyocytes Derived from Human Pluripotent Stem Cells Using miRNA Switches.利用 miRNA 开关从人多能干细胞中分离心肌细胞。
Methods Mol Biol. 2021;2320:35-51. doi: 10.1007/978-1-0716-1484-6_5.
6
High efficiency differentiation of human pluripotent stem cells to cardiomyocytes and characterization by flow cytometry.人多能干细胞高效分化为心肌细胞及流式细胞术鉴定
J Vis Exp. 2014 Sep 23(91):52010. doi: 10.3791/52010.
7
JAK2 as a surface marker for enrichment of human pluripotent stem cells-derived ventricular cardiomyocytes.JAK2 作为一种表面标志物,用于富集人多能干细胞来源的心室肌细胞。
Stem Cell Res Ther. 2023 Dec 13;14(1):367. doi: 10.1186/s13287-023-03610-2.
8
A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.一种用于人多能干细胞衍生心肌细胞的具有代谢纯化功能的大规模悬浮培养系统。
Stem Cells Transl Med. 2014 Dec;3(12):1473-83. doi: 10.5966/sctm.2014-0072. Epub 2014 Oct 29.
9
A Comparative Assessment of Marker Expression Between Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells and the Developing Pig Heart.人诱导多能干细胞心肌细胞分化与猪心脏发育过程中标志物表达的比较评估
Stem Cells Dev. 2021 Apr 1;30(7):374-385. doi: 10.1089/scd.2020.0184.
10
Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.在特定条件下人多能干细胞向心肌细胞的分化
Methods Mol Biol. 2016;1353:163-80. doi: 10.1007/7651_2014_178.

引用本文的文献

1
Genome-wide CRISPR screen identifies Menin and SUZ12 as regulators of human developmental timing.全基因组CRISPR筛选确定Menin和SUZ12为人类发育时间的调节因子。
Nat Cell Biol. 2025 Sep 2. doi: 10.1038/s41556-025-01751-5.
2
AI-guided laser purification of human iPSC-derived cardiomyocytes for next-generation cardiac cell manufacturing.用于下一代心脏细胞制造的人工智能引导的人诱导多能干细胞衍生心肌细胞激光纯化
Commun Biol. 2025 May 13;8(1):745. doi: 10.1038/s42003-025-08162-0.
3
GATA6 regulates WNT and BMP programs to pattern precardiac mesoderm during the earliest stages of human cardiogenesis.在人类心脏发生的最早阶段,GATA6调节WNT和BMP程序以形成心脏前中胚层模式。
Elife. 2025 Mar 13;13:RP100797. doi: 10.7554/eLife.100797.
4
Billion-Scale Expansion of Functional hiPSC-Derived Cardiomyocytes in Bioreactors Through Oxygen Control and Continuous Wnt Activation.通过氧气控制和持续的Wnt激活在生物反应器中实现功能性人诱导多能干细胞衍生心肌细胞的十亿级扩增
Adv Sci (Weinh). 2025 Mar;12(11):e2410510. doi: 10.1002/advs.202410510. Epub 2025 Jan 23.
5
In Vitro Models of Cardiovascular Disease: Embryoid Bodies, Organoids and Everything in Between.心血管疾病的体外模型:胚状体、类器官及二者之间的一切。
Biomedicines. 2024 Nov 27;12(12):2714. doi: 10.3390/biomedicines12122714.
6
Single-cell transcriptome analysis reveals CD34 as a marker of human sinoatrial node pacemaker cardiomyocytes.单细胞转录组分析揭示 CD34 作为人心房结起搏心肌细胞的标志物。
Nat Commun. 2024 Nov 27;15(1):10206. doi: 10.1038/s41467-024-54337-4.
7
miR-24-3p secreted as extracellular vesicle cargo by cardiomyocytes inhibits fibrosis in human cardiac microtissues.心肌细胞作为细胞外囊泡货物分泌的miR-24-3p可抑制人心脏微组织中的纤维化。
Cardiovasc Res. 2025 Apr 15;121(1):143-156. doi: 10.1093/cvr/cvae243.
8
Transient Notch Activation Converts Pluripotent Stem Cell-Derived Cardiomyocytes Towards a Purkinje Fiber Fate.短暂的Notch激活将多能干细胞衍生的心肌细胞转变为浦肯野纤维命运。
bioRxiv. 2024 Sep 28:2024.09.22.614353. doi: 10.1101/2024.09.22.614353.
9
Cardiomyocyte-derived circulating extracellular vesicles allow a non-invasive liquid biopsy of myocardium in health and disease.心肌细胞衍生的循环细胞外囊泡可实现对健康和疾病状态下心肌的无创液体活检。
medRxiv. 2024 Sep 22:2024.09.19.24314009. doi: 10.1101/2024.09.19.24314009.
10
Improving human cardiac organoid design using transcriptomics.利用转录组学改善人心肌类器官设计。
Sci Rep. 2024 Aug 30;14(1):20147. doi: 10.1038/s41598-024-61554-w.

本文引用的文献

1
Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines.阶段特异性激活素/ nodal 和 BMP 信号转导促进小鼠和人多能干细胞系的心脏分化。
Cell Stem Cell. 2011 Feb 4;8(2):228-40. doi: 10.1016/j.stem.2010.12.008.
2
Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells.TGFβ 家族成员和 WNT 的阶段特异性信号转导调节人多能干细胞的模式形成和胰腺特化。
Development. 2011 Mar;138(5):861-71. doi: 10.1242/dev.055236. Epub 2011 Jan 26.
3
Identification of an FHL1 protein complex containing ACTN1, ACTN4, and PDLIM1 using affinity purifications and MS-based protein-protein interaction analysis.通过亲和纯化和基于质谱的蛋白质-蛋白质相互作用分析鉴定包含α-辅肌动蛋白1(ACTN1)、α-辅肌动蛋白4(ACTN4)和PDLIM1的FHL1蛋白复合物。
Mol Biosyst. 2011 Apr;7(4):1185-96. doi: 10.1039/c0mb00235f. Epub 2011 Jan 18.
4
An engineered cardiac reporter cell line identifies human embryonic stem cell-derived myocardial precursors.工程化心脏报告细胞系鉴定人胚胎干细胞来源的心肌前体细胞。
PLoS One. 2011 Jan 4;6(1):e16004. doi: 10.1371/journal.pone.0016004.
5
Modelling the long QT syndrome with induced pluripotent stem cells.利用诱导多能干细胞构建长 QT 综合征模型。
Nature. 2011 Mar 10;471(7337):225-9. doi: 10.1038/nature09747. Epub 2011 Jan 16.
6
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome.LEOPARD 综合征的患者特异性诱导多能干细胞衍生模型。
Nature. 2010 Jun 10;465(7299):808-12. doi: 10.1038/nature09005.
7
Nongenetic method for purifying stem cell-derived cardiomyocytes.非遗传方法纯化干细胞来源的心肌细胞。
Nat Methods. 2010 Jan;7(1):61-6. doi: 10.1038/nmeth.1403. Epub 2009 Nov 29.
8
Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue.无支架血管化人心脏肌肉组织的生理功能与移植
Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16568-73. doi: 10.1073/pnas.0908381106. Epub 2009 Sep 17.
9
Cardiomyocyte differentiation of human induced pluripotent stem cells.人诱导多能干细胞的心肌细胞分化
Circulation. 2009 Oct 13;120(15):1513-23. doi: 10.1161/CIRCULATIONAHA.109.868885. Epub 2009 Sep 28.
10
Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.再生医学与药物研发中来自人类多能干细胞的心肌细胞。
Trends Pharmacol Sci. 2009 Oct;30(10):536-45. doi: 10.1016/j.tips.2009.07.001. Epub 2009 Sep 15.